BridgeBio Pharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $631.7M
Liabilities Breakdown FY2019
Total Liabilities: $155.7M
Asset Breakdown
Total Assets: $631.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $363.8M | 57.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.6M | 0.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $262.3M | 41.5% |
Liabilities Breakdown
Total Liabilities: $155.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.9M | 5.7% |
| Long-Term Debt | $91.8M | 59.0% |
| Other Liabilities | $55.1M | 35.4% |